Guided Therapeutics, Inc. GTHP

GTHP Company Overview

Guided Therapeutics, Inc. (OTCQB: GTHP) is a medical technology company focused on the development and commercialization of diagnostic devices intended to improve the early detection of cervical disease and cervical cancer. The company operates within the healthcare technology and medical diagnostics industries, with its primary emphasis on non-invasive screening technologies for women’s health. Its principal product platform has been the LuViva Advanced Cervical Scan, a device designed to identify cervical abnormalities using optical spectroscopy without requiring tissue removal or laboratory processing during the initial screening step.

The company’s core business model has centered on commercialization, regulatory advancement, and licensing opportunities tied to the LuViva platform and related intellectual property. Guided Therapeutics historically targeted healthcare providers, women’s health clinics, and international screening programs, particularly in markets where access to conventional cytology-based screening infrastructure is limited. The company was founded in the 1990s and evolved from a development-stage medical device enterprise into a commercialization-focused organization pursuing regulatory approvals, distribution relationships, and international market expansion for cervical cancer detection technologies.